(Q39144797)

9 September 2017

title

Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis (English)

1 reference

9 September 2017

0 references

1 reference

8

G C Kundu

1 reference

9 September 2017

R Raja

1

1 reference

9 September 2017

S Kale

2

1 reference

9 September 2017

D Thorat

3

1 reference

9 September 2017

G Soundararajan

4

1 reference

9 September 2017

K Lohite

5

1 reference

9 September 2017

A Mane

6

1 reference

9 September 2017

S Karnik

7

1 reference

9 September 2017

language of work or name

English

0 references

publication date

3 June 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

33

1 reference

9 September 2017

issue

16

1 reference

9 September 2017

page(s)

2053-2064

1 reference

Hypoxia--a key regulatory factor in tumour growth

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Hypoxia, clonal selection, and the role of HIF-1 in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

The hypoxic tumour microenvironment and metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

HIF-1 and HIF-2 transcription factors--similar but not identical

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Hypoxia-inducible factor-1 and p53: friends, acquaintances, or strangers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

PHD2 in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

How does PKMζ maintain long-term memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Biological consequences of tumor hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Investigating hypoxic tumor physiology through gene expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Osteopontin: role in cell signaling and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Role of osteopontin in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

The role of Osteopontin in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Small integrin-binding proteins as serum markers for prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Osteopontin: a potentially important therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Systemic endocrine instigation of indolent tumor growth requires osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Inflammation, but not hypoxia, mediated HIF-1alpha activation depends on COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

GAPDH is not regulated in human glioblastoma under hypoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

TNFalpha induces HIF-1alpha expression through activation of IKKbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Regulation of transcription of hypoxia-inducible factor-1α (HIF-1α) by heat shock factors HSF2 and HSF4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Regulation of tumor angiogenesis by integrin-linked kinase (ILK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Regulation of hypoxia-inducible factor-1alpha by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

17-beta estradiol attenuates hypoxic induction of HIF-1alpha and erythropoietin in Hep3B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

2-methoxyestradiol in the pathophysiology of endometriosis: focus on angiogenesis and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Prostaglandin E2 regulates tumor angiogenesis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

NIH Image to ImageJ: 25 years of image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Direct Transcriptional Up-regulation of Cyclooxygenase-2 by Hypoxia-Inducible Factor (HIF)-1 Promotes Colorectal Tumor Cell Survival and Enhances HIF-1 Transcriptional Activity during Hypoxia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

Hypoxia regulates endothelin-1 production by the inner medullary collecting duct

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.171

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.171

1 reference

9 September 2017

1 reference